Dermatol. praxi. 2011;5(3):156-159

Ciclosporin A in treating toxic epidermal necrolysis

MUDr.David Nešpor2, MUDr.Břetislav Lipový1,2, MUDr.Nora Gregorová1
1 Klinika popálenin a rekonstrukční chirurgie FN Brno
2 Lékařská fakulta Masarykovy univerzity Brno

Toxic epidermal necrolysis was first described by Alan Lyell, a Scottish dermatologist, in 1956. That is why this nosological entity is also

referred to as Lyell’s syndrome. It is an extremely rare disease characterized by extensive epidermal necrolysis and systemic toxicity.

Only an early diagnosis, immediate initiation of treatment, good-quality nutrition and wound care along with accurate microbiological

monitoring can improve the prognosis of patients with this disease. We report a case of a severely affected young Vietnamese woman

treated with ciclosporin A.

Keywords: toxic epidermal necrolysis, ciclosporin A

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nešpor D, Lipový B, Gregorová N. Ciclosporin A in treating toxic epidermal necrolysis. Dermatol. praxi. 2011;5(3):156-159.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schulz JT, Sheridan RL, Ryan CM, et al. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000; 21(3): 199-204. Go to original source... Go to PubMed...
    2. Becker DS. Toxic epidermal necrolysis. Lancet 1998; 351: 1417-1420. Go to original source... Go to PubMed...
    3. Murphy JT, Purdue GF, Hunt JL. Toxic epidermal necrolysis. J Burn Care Rehabil 1997; 18: 417-420. Go to original source...
    4. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333(24): 1600-1607. Go to original source... Go to PubMed...
    5. Saiag P, Caumes E, Chosidow O, et al. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1990; 26: 567-574. Go to original source... Go to PubMed...
    6. Elias PM, Fritsch P, Epstein EH. Staphylococcal scalded skin syndrome: clinical features, pathogenesis, and recent microbiological and biochemici developments. Arch Dermatol 1977; 113: 207-219. Go to original source... Go to PubMed...
    7. Dancer SJ, Garratt R, Sanhanha J, et al. The epidermolytic toxins are serine proteases. FEBS Lett 1990; 268: 129-132. Go to original source... Go to PubMed...
    8. Pasricha JS, et al. Toxic epidermal necrolysis. Int. J Dermatol. 1996; 35: 523-527. Go to original source... Go to PubMed...
    9. Sanwo M, et al. Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS. J Allergy Clin. Immunol. 1996; 98: 1112-1115. Go to original source... Go to PubMed...
    10. Paquet P, et al. Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatol. 1999; 198: 198-202. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.